Paid Clinical Trials in Jackson, MS
As of August 2026, 154 paid clinical trials are recruiting in Jackson, Mississippi. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Jackson offers studies at sites including University of Mississippi Medical Center for conditions such as Heart Failure, Hypertension, Malignant Solid Neoplasm, Obesity. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Jackson
Trials by drug in Jackson
Filter results
Newly added in Jackson
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component
144 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Pelacarsen Roll-over Extension Program
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism With the Indigo Aspiration System
Caris Biorepository Research Protocol
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
The PERSEVERE Study
BOOM-IBD2 Pivotal Clinical Trial
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
Lysosomal Acid Lipase (LAL) Deficiency Registry
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt
Top Research Study Locations in Jackson
Researchers run research studies in Jackson, MS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Mississippi Medical Center | B Acute Lymphoblastic Leukemia, Down Syndrome, Stage II Lung Cancer AJCC v8 | 95 |
| Mississippi Baptist Medical Center | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 7 |
| Jackson Heart Clinic | Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Cryptogenic Stroke | 6 |
| University of Mississippi | Acute Decompensated Heart Failure, Breast Reconstruction Surgery, Gestational Hypertension | 4 |
| University of Mississippi Medical Center - Children's of Mississippi | Infant, Low Birth Weight, Infant, Newborn, Infant, Premature | 3 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 2 |
| Jackson Oncology Associates | Cancer, Early Breast Cancer, Early Detection of Cancer | 2 |
| Jackson Oncology Associates PLLC | Epidermal Growth Factor Receptor Gene Mutation, Malignant Solid Neoplasm, Non Small Cell Lung Cancer | 2 |
| The University of Mississippi Medical Center | Anterior Cruciate Ligament Reconstruction Rehabilitation, Diffuse Large B-Cell Lymphoma | 2 |
| Jackson Oncology Associates, PLLC | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| AURORA-1 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AURORA-2 Clinical Site | Chronic Weight Management, Obesity, Overweight | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Allied Health Clinical Research Organization, LLC - Jackson | Crohn's Disease | 1 |
| Batson Children's Hospital-University of Mississippi Medical Center | Hypoplastic Left Heart Syndrome (HLHS) | 1 |
| Cade Chapel - Center for Family Life, Inc. | Nutrition Security | 1 |
| Children's of Mississippi | Congenital Heart Disease (CHD) | 1 |
| Direct Biologics Investigational Site | ARDS, Acute Respiratory Distress Syndrome | 1 |
| Elite Clinical Research | Atherosclerotic Cardiovascular Disease | 1 |
| EyePoint Investigational Site | Cataract | 1 |
| GI Alliance | Inflammatory Bowel Diseases, Ulcerative Colitis | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Jackson Heart Clinic, P.A. | Heart Failure | 1 |
| Jackson Oncology Associates - The Hederman Cancer Center | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Jackson State University/Department of Behavioral & Environmental Health | Contraception, Family Dynamics, Family Structure | 1 |
Active & Upcoming Studies in Jackson (2026)
Recruiting trials in Jackson grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (58 active studies)
- Evaluation of Endobronchial Ultrasound Needle Cleaning Techniques and Their Impact on Specimen Contamination · University of Mississippi Medical Center
- Statewide Optimization of Lung Cancer Screening Utilizing the QUILS™ System in Nevada and Mississippi: State-Based Initiative Component · Timothy Mullett
Cardiovascular (18 active studies)
- VWCR to Improve Cardiovascular Health and Outcomes Among Cardiac Patients: A Multicenter Randomized Clinical Trial Protocol (Destination Cardiac Rehab Study) · Mayo Clinic
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Diabetes & metabolic (7 active studies)
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes · Phase 3 · Ascletis Pharma (China) Co., Limited
- A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities · Phase 3 · Ascletis Pharma (China) Co., Limited
Neurology & pain (5 active studies)
- Low Dose Bolus Ketamine For Use In Sickle Cell Pain Crisis · Phase 4 · University of Mississippi Medical Center
- Encore PFO Closure Device - The PerFOrm Trial · Encore Medical Inc.
HIV / STI (4 active studies)
- A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011) · Phase 3 · Merck Sharp & Dohme LLC
- Intervention to Enhance PrEP Persistence · Brown University
Pediatric (4 active studies)
- Vitamin A Supplementation and Breast Milk Vitamin A Levels in Mothers of Preterm Infants · University of Mississippi Medical Center
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) · Duke University
Mental health & behavior (2 active studies)
Eye & vision (2 active studies)
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
- Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract · Phase 4 · EyePoint Pharmaceuticals, Inc.
Vaccines (1 active study)
Common conditions studied in Jackson
- Heart Failure (4 active studies)
- Hypertension (4 active studies)
- Malignant Solid Neoplasm (4 active studies)
- Obesity (4 active studies)
- B Acute Lymphoblastic Leukemia (3 active studies)
- Down Syndrome (3 active studies)
Leading research sponsors in Jackson
- Children's Oncology Group
- National Cancer Institute (NCI)
- University of Mississippi Medical Center
- SWOG Cancer Research Network
- Duke University
Frequently asked questions
How many paid clinical trials are currently recruiting in Jackson?
There are approximately 154 recruiting clinical trials in Jackson, Mississippi listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Jackson pay participants?
Most recruiting trials in Jackson compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Jackson?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Jackson?
The most common conditions under active study in Jackson include Heart Failure (4), Hypertension (4), Malignant Solid Neoplasm (4), Obesity (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Jackson?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Jackson on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Jackson?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Jackson?
Recruiting research sites in Jackson include University of Mississippi Medical Center, Mississippi Baptist Medical Center, Jackson Heart Clinic, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Jackson right now?
The largest active categories in Jackson are Cancer & tumors (58), Cardiovascular (18), Diabetes & metabolic (7). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.